Literature DB >> 3937584

The effect of prednisolone on kidney calcification in vitamin D-treated rats.

G Sjöden, U Lindgren.   

Abstract

Glucocorticoids are often used to treat hypercalcemia due to vitamin D overdosage. We measured the effect of 1.5 mg/day of prednisolone on the amount of calcium deposited in the kidney of rats dosed with either 500 ng/d or 2000 ng/day of 1-alpha OHD2 or 1-alpha OHD3. The rats were given a diet containing 0.3% calcium and 0.5% phosphate. A second group of rats received 2000 ng/d of the vitamin D analogs and a diet which contained only 0.02% calcium. After 6 weeks, rats given the vitamin D analogs had two to six times more calcium in the kidney compared with the controls (0.096-0.276 mg vs. 0.240-1.064 mg). When a pharmacological dose of prednisolone was added to treatment, calcium in renal tissue increased to 0.305-3.083 mg. The urinary output of calcium seemed to be increased by prednisolone whereas the serum calcium was lowered. It appears that glucocorticoids given at the same time as vitamin D compounds increases the risk for nephrocalcinosis possibly due to increased amounts of calcium in the urine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3937584     DOI: 10.1007/bf02554918

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  23 in total

Review 1.  HYPERCALCAEMIC NEPHROPATHY.

Authors:  A M PARFITT
Journal:  Med J Aust       Date:  1964-07-25       Impact factor: 7.738

2.  Vitamin D intoxication: report of two cases treated with cortisone.

Authors:  J V VERNER; F L ENGEL; H T McPHERSON
Journal:  Ann Intern Med       Date:  1958-04       Impact factor: 25.391

3.  Effect of glucocorticoids on function of the parathyroid glands in man.

Authors:  R F Fucik; S C Kukreja; G K Hargis; E N Bowser; W J Henderson; G A Williams
Journal:  J Clin Endocrinol Metab       Date:  1975-01       Impact factor: 5.958

Review 4.  Kidney and adrenocortical hormones.

Authors:  C R Kleeman; J Levi; O Better
Journal:  Nephron       Date:  1975       Impact factor: 2.847

5.  Effect of 1,25-dihydroxyvitamin D3 on osteopenia induced by prednisolone in adult rats.

Authors:  J U Lindgren; C R Merchant; H F DeLuca
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

6.  Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.

Authors:  M R Hughes; D J Baylink; P G Jones; M R Haussler
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

7.  Glucocorticoid effects in vitamin D intoxication.

Authors:  W F Streck; C Waterhouse; J G Haddad
Journal:  Arch Intern Med       Date:  1979-09

8.  1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure.

Authors:  A S Brickman; J W Coburn; S G Massry; A W Norman
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

9.  Oral 1,25(OH)2D3: an effective prophylactic treatment for glucocorticoid osteopenia in rats.

Authors:  J U Lindgren; H F DeLuca
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

10.  Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.

Authors:  C Christiansen; P Rødbro; M S Christensen; B Hartnack; I Transbøl
Journal:  Lancet       Date:  1978-09-30       Impact factor: 79.321

View more
  1 in total

1.  Infants With Congenital Adrenal Hyperplasia Are at Risk for Hypercalcemia, Hypercalciuria, and Nephrocalcinosis.

Authors:  Melissa J Schoelwer; Vidhya Viswanathan; Amy Wilson; Corina Nailescu; Erik A Imel
Journal:  J Endocr Soc       Date:  2017-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.